$ABEV

Ambev (ABEV) Q2 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 4:00 a.m. ET CALL PARTICIPANTS CEO - Carlos Eduardo Lisboa CFO and Investor Relations Officer - Guilherme Fleury de Figueiredo Parolari TAKEAWAYS Normalized EBITDA -- BRL 6.4 billion, representing 8.9% growth and 80 basis points of margin expansion driven by disciplined decisions across cost and revenue management. Normalized EPS -- BRL 0.22, a 24.2% increase compared to the previous year, supported by improved operating results and lower net financial expenses.

Original reporting
Published Jul 31, 2026, 2:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 2:41 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Ambev (ABEV) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$ABEVBullishMed
01

Why it matters

The disclosed metrics support a constructive read-through on operating leverage and cash generation, while management’s risk notes (FX translation, Brazil NAB recovery timing, consumer debt) flag potential near-term earnings volatility.

02

Market read

Traders can update expectations for Ambev’s margin trajectory, cash generation, and segment mix, while monitoring FX and Brazil non-alcohol demand risks.

03

What to watch

Brazil NAB volumes declined 4.4% and management cited elevated household debt; these could limit demand recovery even if premium and balanced choices remain strong.

Relevance 7/10Novelty 6/10Timing: earnings call transcript released pre-market July 31

Background

This is a transcript of Ambev’s 2026 Q2 earnings call, covering normalized profitability, volumes by segment, cash flow, and shareholder returns.

Company-level read

Ticker impact

$ABEVBullishMedium confidence
Context

Ambev reported Q2 normalized EBITDA of BRL 6.4B (+8.9%) and normalized EPS of BRL 0.22 (+24.2%) on the earnings call.

Expected impact

Near-term bias modestly positive, with volatility risk tied to FX translation and non-alcohol volume trends.

Evidence & confidence

The article discloses multiple quantified operating and financial metrics (EBITDA, EPS, cash flow, buyback execution) plus explicit risk commentary on Bolivian FX devaluation and Brazil NAB volume decline.

Market effects

Highlights ongoing premium and non-alcohol category mix shifts in LatAm beer, with digital marketplace GMV growth as a monetization lever.

Emphasizes Brazil consumer debt sensitivity and Bolivia logistics disruption, both of which can affect volumes and reported results.

Shows how FX translation and regional macro conditions can swing reported financials for multinational beverage peers.

Counterpoint

Reported EPS and EBITDA growth may be partly influenced by non-cash items (e.g., FX reserve conversion gains), which could fade and pressure forward earnings quality.

Key entities

  • Ambev

    Brazilian beverage company reporting Q2 2026 normalized EBITDA, EPS, volumes, cash flow, and buyback execution.

  • Carlos Eduardo Lisboa

    CEO who discussed premium/balanced growth, FIFA World Cup activation strategy, and Ze Delivery performance.

  • Guilherme Fleury de Figueiredo Parolari

    CFO who cited margin expansion drivers, cash flow improvement, and FX-related financial expense dynamics.

Related articles

$SHOPMedAI 8/10

Shopify Was Supposed to Be an AI Casualty. Its AI-Referred Traffic Just Tripled.

Shopify (SHOP) reported Q2 results, citing AI-referred traffic to merchants’ storefronts that tripled year over year and orders that began with AI search also tripled. New buyers from AI channels placed orders at nearly twice the rate of other channels. Revenue rose 34% to $3.6B, GMV reached $115.6B, operating income rose 68% to $488M, and free cash flow was $654M.

$GPRKMed

Geopark Q2 Earnings Call Highlights

Geopark (NYSE:GPRK) reported Q2 earnings call updates. It plans $40m to $50m of Vaca Muerta investment in 2H 2026 after $55m in 1H, with 70% to 80% in Q3. Full-year lifting costs are guided at $17 to $19/bbl. Cash rose to $316m, net leverage fell to 1.2x EBITDA, and a $0.023/share quarterly dividend was declared.

$GRDNMed

Guardian Pharmacy Services Q2 Earnings Call Highlights

Guardian Pharmacy Services (GRDN) reported Q2 net income of $22.1M vs $8.8M a year earlier, including an $8.5M payer-dispute settlement recorded as other income. The company expects H2 revenue to fall low-single digits YoY due to IRA pricing reductions, with adjusted EBITDA margin stable in Q3 and seasonally higher in Q4. It also appointed Morris as COO and named a new CFO.

$GPNMed

Global Payments Q2 Earnings Call Highlights

Global Payments (NYSE:GPN) reported Q2 results and discussed its Worldpay integration and Genius point-of-sale rollout. Management guided for about 4.5% revenue growth in 2H, margins near 43%, and cited drivers including sales-force ramp and enterprise go-lives. Q2 adjusted net revenue by segment: SMB $1.51B, Enterprise $838M, Platforms $628M. Adjusted free cash flow was $687M; net leverage just below 3.5x.

$CXWMed

Private prisons announce $1.4 billion in revenue as immigration detentions climb

CoreCivic and GEO Group reported combined $1.4 billion in quarterly revenue for April-June as U.S. immigration detention nears record levels. CoreCivic said revenue rose 27% to $684.9 million, including a $1.6 billion DHS facility sale not yet reflected. GEO Group reported $732.1 million revenue, up 15%, with growth in ICE ankle monitoring and related services.

$CATMedAI 8/10

Critical Minerals: How Data Centres are Boosting Caterpillar

Caterpillar shares rose about 12% on 4 August after its Q2 results beat analyst expectations. The company reported revenue of $20.54bn, up 24% year on year, and adjusted EPS of $8.17 versus $6.20 expected. Operating profit was $4.3bn. Order backlog reached $72.1bn, up 92%, supporting construction and power demand tied to data centres.